Your browser doesn't support javascript.
loading
Validation of the Prevention Impacts Simulation Model (PRISM).
Yarnoff, Benjamin; Honeycutt, Amanda; Bradley, Christina; Khavjou, Olga; Bates, Laurel; Bass, Sarah; Kaufmann, Rachel; Barker, Lawrence; Briss, Peter.
  • Yarnoff B; RTI International, Research Triangle Park, North Carolina.
  • Honeycutt A; RTI International, 3040 E. Cornwallis Rd, Research Triangle Park, NC 27709. Email: byarnoff@rti.org.
  • Bradley C; RTI International, Research Triangle Park, North Carolina.
  • Khavjou O; RTI International, Research Triangle Park, North Carolina.
  • Bates L; RTI International, Research Triangle Park, North Carolina.
  • Bass S; RTI International, Research Triangle Park, North Carolina.
  • Kaufmann R; RTI International, Research Triangle Park, North Carolina.
  • Barker L; Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Briss P; Centers for Disease Control and Prevention, Atlanta, Georgia.
Prev Chronic Dis ; 18: E09, 2021 02 04.
Article en En | MEDLINE | ID: mdl-33544072
ABSTRACT

INTRODUCTION:

Demonstrating the validity of a public health simulation model helps to establish confidence in the accuracy and usefulness of a model's results. In this study we evaluated the validity of the Prevention Impacts Simulation Model (PRISM), a system dynamics model that simulates health, mortality, and economic outcomes for the US population. PRISM primarily simulates outcomes related to cardiovascular disease but also includes outcomes related to other chronic diseases that share risk factors. PRISM is openly available through a web application.

METHODS:

We applied the model validation framework developed independently by the International Society of Pharmacoeconomics and Outcomes Research and the Society for Medical Decision Making modeling task force to validate PRISM. This framework included model review by external experts and quantitative data comparison by the study team.

RESULTS:

External expert review determined that PRISM is based on up-to-date science. One-way sensitivity analysis showed that no parameter affected results by more than 5%. Comparison with other published models, such as ModelHealth, showed that PRISM produces lower estimates of effects and cost savings. Comparison with surveillance data showed that projected model trends in risk factors and outcomes align closely with secular trends. Four measures did not align with surveillance data, and those were recalibrated.

CONCLUSION:

PRISM is a useful tool to simulate the potential effects and costs of public health interventions. Results of this validation should help assure health policy leaders that PRISM can help support community health program planning and evaluation efforts.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Política de Salud / Modelos Teóricos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Política de Salud / Modelos Teóricos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article